Navigation Links
UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
Date:4/3/2012

eir nature, such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions which could cause actual results to differ materially from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, the inability to obtain necessary regulatory approvals or to obtain them on acceptable terms, costs associated with research and development, changes in the prospects for products in the pipeline or under development by UCB, effects of future judicial decisions or governmental investigations, product liability claims, challenges to patent protection for products or product candidates, changes in laws or regulations, exchange rate fluctuations,  changes or uncertainties in tax laws or the administration of such laws and hiring and retention of its employees.  UCB is providing this information as of the date of this press release and expressly disclaims any duty to update any information contained in this press release, either to confirm the actual results or to report a change in its expectations.

There is no guarantee that new product candidates in the pipeline will progress to product approval or that new indications for existing products will be developed and approved. Products or potential products which are the subject of partnerships, joint ventures or licensing collaborations may be subject to differences between the partners. Also, UCB or others could discover safety, side effects or manufacturing problems with its products after they are marketed.

Moreover, sales may be impacted by international and domestic trends toward managed care and health care cost containment and the reimbursement policies imposed by third-party payers as well as legislation affecting biopharmaceutical pricing and reimbursement.

Abou
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Md. , March 26, 2015  RegeneRx Biopharmaceuticals, ... it has received a patent acceptance notice from the ... 4 (TB4) to prevent or reduce tissue damage caused ... the case when cardiac vessels are opened after a ... when treating stroke victims. Damage can be ...
(Date:3/26/2015)... , March 26, 2015  Becton, Dickinson and Company ... will commence offers to exchange all validly tendered and ... Corporation, a wholly owned subsidiary of BD, for notes ... table below. A Registration Statement on Form S-4 (the ... Notes was filed with the Securities and Exchange Commission ...
(Date:3/26/2015)... IGI Laboratories, Inc. (NYSE MKT: IG), a ... pharmaceutical company, today announced it has submitted its first ... and Drug Administration (FDA) of 2015, which brings the ... the FDA to twenty-three. Jason Grenfell-Gardner ... March 2, 2015, we committed to file at least ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 2
... Holdings, Inc. (Nasdaq: UCTT ), a developer ... equipment, medical device, energy, research, and flat panel industries, ... and Casey Eichler, Chief Financial Officer, will address the ... place at the New York Palace Hotel, New York ...
... STOUGHTON, Mass., Jan. 5, 2011 SyncMedical ... de Vigilancia Sanitaria – Brazilian National Health Surveillance Agency) ... System for sale in Brazil. SyncMedical,s Ethos Spine product ... and cost effective treatment solutions to surgeons in the ...
Cached Medicine Technology:SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil 2
(Date:3/27/2015)... April 2015 is the 150th anniversary of the end of ... war and the amazing President that led our country through ... Civil War and Abraham Lincoln. This moving event will be ... Pickens Theater in Newport, RI. , Chief Justice (Ret.) ... master of ceremonies. Dr. Fred Zilian, educator, writer and actor, ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 The Florida ... Accelerate Brain Cancer Cure (ABC2), awarded $350,000 to support ... of Florida, The Scripps Research Institute and H. Lee ... support studies with a clear development path and potential ... in the near future. , The awards fund ...
(Date:3/26/2015)... Houston, TX (PRWEB) March 27, 2015 ... is proud to announce prestigious victories at the 2015 ... The ranch was quite successful across many categories of ... of our performance at the ABBA International Brahman show,” ... enjoys friendly competition, and the proof of our superior ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Dr. ... 32nd annual Dallas Rhinoplasty Symposium and has trained ... reiterated the importance of evidence based medicine (EBM), that ... from well conducted research. , "We often hear from ... rhinoplasty, and while we are certainly not trying to ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 UC Davis ... research into the origins of schizophrenia: A Silvio O. ... of only 15 such centers in the United States. ... million grant from the National Institutes of Mental Health, ... the novel hypothesis that an origin of schizophrenia may ...
Breaking Medicine News(10 mins):Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3Health News:Red and Gray Brahman Cattle Champions Announced by Moreno Ranches at International Brahman Show and Sale in Houston, Texas 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4
... Dec. 10 The American Botanical Council (ABC) has ... http://www.themeaningoftea.com ) adoption of tea ( Camellia sinensis ). ... provide ABC financial support to ensure that abstracts (summaries) ... tea are made available within ABC,s HerbMedPro database, one ...
... Management (IIM), a fee-only registered investment adviser based in the Florida ... in November of 18.5%. , ... ISLAMORADA, Fla. ... is an innovative alternative to actively managed mutual funds. Unlike most ...
... over Q3 2007 , , Gross margin ... CITY, China, Dec. 10 Sinobiopharma, Inc. (OTC Bulletin Board: SNBP)("Sinobiopharma", or ... the third quarter ended September 30, 2008 for Sinobiopharma,s operating subsidiary, Dong ... , Financial highlights include: , , ...
... companies and universities are racing to develop drugs that use ... a host of diseases. Now, a new study opens up ... the University of Georgia have demonstrated for the first time ... the development of vaccines. , "Our data suggest that, ...
... A University of British Columbia geneticist has discovered a gene ... uveal melanoma. , Catherine Van Raamsdonk, an assistant professor of ... team of researchers, have discovered a genetic mutation in a ... cent of the cases of uveal melanoma. , The findings, ...
... studies have shown treadmill desks superior to vitamin supplementation ... ... 10, 2008 -- On the heels of announcements two weeks ago ... various forms of cancers come two more medical announcements with the ...
Cached Medicine News:Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 3Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 4Health News: Tarpon Fund Posts Strong Early Results : Innovative Fund From Islamorada Investment Management Gains 18.5% in November 2Health News: Tarpon Fund Posts Strong Early Results : Innovative Fund From Islamorada Investment Management Gains 18.5% in November 3Health News:Sinobiopharma Reports Highlights of Third Quarter Results for Its Operating Subsidiary, Dong Ying China 2Health News:Study first to show that RNA interference can facilitate vaccine development 2Health News:Study first to show that RNA interference can facilitate vaccine development 3Health News:UBC researchers discover gene mutation that causes eye cancer 2Health News:Treadmill Desks More Effective in Decreasing Prostate Cancer Risks Than Vitamin and Antioxidant Supplements 2
... oximetry monitoring system compatible with personal ... Extremely rugged and cost-effective.The BCI 3301 ... delivers pulse oximetry wherever spot-checking is ... clinics and hospitals. In fact, its ...
... ReZoom intraocular lens is a second-generation ... patients with greater independence from glasses than ... provides a range of vision that monfocals ... Optics technology distributes light over five optic ...
Engineered for high volume surgical efficiencies, the Bausch & Lomb Hansatome Microkeratome, a corneal resection instrument, features an automated pivoting motion that provides smooth, resistance-fre...
... breaks through previous boundaries in CT ... to improve diagnostic confidence, image quality ... thin-slice coverage, the 64-channel broadens horizons ... coronary artery evaluation. The 64-channel configuration ...
Medicine Products: